medigraphic.com
ISSN 2078-7170 (Electronic)

2015, Number 3

<< Back Next >>

CorSalud 2015; 7 (3)

Programmed electrical pacing of the heart in Brugada Syndrome. Part II: Variations on the same topic

Dorantes SM, Trung CP

Language: Spanish
References: 66
Page: 202-213
PDF size: 392.40 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AA, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126-33.

  2. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol. 2001;12:1004-7.

  3. Stephenson EA, Berul CI. Electrophysiological interventions for inherited arrhythmia syndromes. Circulation. 2007;116:1062-80.

  4. Viskin S, Rogowski O. Asymptomatic Brugada syn-drome: a cardiac ticking time-bomb?. Europace. 2007;9:707-10.

  5. Viskin S. Brugada syndrome in children. Don’t ask, don’t tell? Circulation. 2007;115:1970-2.

  6. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, et al. Risk stratification in Brugada syndrome. Results of the PRELUDE (PRo-grammed ELectrical stimUlation preDictive valuE) Registry. J Am Coll Cardiol. 2012;59:37-45.

  7. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-450.

  8. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS Expert Consensus State-ment on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932-63.

  9. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Bru-gada syndrome. A multicenter study. Circulation. 2006;114:2317-24.

  10. 10.Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Kowatsu Y, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Circulation. 2013;128:1739-47.

  11. 11.Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a pros-pective registry. Heart Rhythm. 2009;6:401-4.

  12. 12.Belhassen B. Is Quinidine the ideal drug for Brugada syndrome? Heart Rhythm. 2012;9:2001-2.

  13. 13.Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of Quinidine in patients with idiopathic ventricular fi-brillation and Brugada syndrome. Pacing Clin Elec-trophysiol. 2009;32:294-301.

  14. 14.Daoulah A, Alsheikh-Ali AA, Ocheltree AH, Ochel-tree S, Al-Kaabi S, Malik M, et al. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syn-drome registry. J Electrocardiol. 2012;45:327-32.

  15. 15.Dorantes M. Apunte histórico sobre la quinidina. CorSalud [Internet]. 2013 [citado 21 Ago 2014];5: 361-5.Disponible en: http://www.corsalud.sld.cu/sumario/2013/v5n4a13/quinidina.html

  16. 16.Viskin S, Wilde AA, Guevara-Valdivia ME, Daoulah A, Krahn AD, Zipes DP, et al. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol. 2013;61:2383-7.

  17. 17.Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation. 2005;112:279-92.

  18. 18.Probst V, Veltmann C, Eckardt L, Meregalli PG, Gai-ta F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome. Results from the FINGER Brugada syndrome Registry. Circula-tion. 2010;121:635-43.

  19. 19.Viskin S, Rosso R. Risk of sudden death in asympto-matic Brugada syndrome: Not as high as we thought and not as low as we wished… but the contrary. J Am Coll Cardiol. 2010;56:1585-8.

  20. 20.Fauchier L, Isorni MA, Clementy N, Pierre B, Simeon E, Babuty D. Prognostic value of programmed ventricular stimulation in Brugada syndrome ac-cording to clinical presentation: an updated meta-analysis of worldwide published data. Int J Cardiol. 2013;168:3027-9.

  21. 21.López A, Dorantes M. Fibrilación ventricular idiopá-tica. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2013 [citado 22 Ago 2014];19:5-12. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/310/323

  22. 22.Champagne J, Geelen P, Philippon F, Brugada P. Re-current cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome. BMC Med [Internet]. 2005 [citado 22 Ago 2014];3:1 [aprox. 6 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC545059/

  23. 23.Lever NA, Newall EG, Larsen PD. Differences in the characteristics of induced and spontaneous epi-sodes of ventricular fibrillation. Europace. 2007;9: 1054-8.

  24. 24.Li L, Zheng X, Dosdall DJ, Huang J, Ideker RE. Differ-ent types of long-duration ventricular fibrillation: can they be identified by electrocardiography. J Electrocardiol. 2012;45:658-9.

  25. 25.Tornés F, Cisneros P, Dorantes M, Castro J, Zayas R, Quiñones MA, et al. Tormenta eléctrica arrítmica en pacientes con cardioversor-desfibrilador automático implantable. Arch Cardiol Mex. 2008;78:68-78.

  26. 26.Dorantes M, Castro J, Tornés F, Quiñones MA, Za-yas R, Dorticós F. Muerte súbita por causa eléctrica en sujetos sin enfermedad cardíaca estructural demostrable. Experiencia cubana. Arch Cardiol Mex. 2004;74:283-9.

  27. 27.Dorantes M, Vázquez A, Castro J, Méndez A. Onda J transitoria después de reanimación por una fibrila-ción ventricular. Rev Argent Cardiol. 2013;81:268-71.

  28. 28.Dorantes-Sánchez M, López-Delgado A, Castro-Hevia J, Méndez-Rosabal A. Intervalo QT corto in-termitente en un paciente con muerte súbita car-diaca. Arch Cardiol Mex. 2011;81:322-6.

  29. 29.Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm. 2009;6:S51-5.

  30. 30.Nam GB. Idiopathic ventricular fibrillation, early repolarization and other J wave-related ventricular fibrillation syndromes. From an electrocardiogra-phic enigma to an electrophysiologic dogma. Circ J. 2012;76:2723-31.

  31. 31.Napolitano C, Bloise R, Monteforte N, Priori SG. Sudden cardiac death and genetic ion channelpa-thies: long QT, Brugada, short QT, catecholaminer-gic polymorphic ventricular tachycardia, and idio-pathic ventricular fibrillation. Circulation. 2012;125: 2027-34.

  32. 32.Aizawa Y, Takatsuki S, Kimura T, Nishiyama N, Fuku-moto K, Tanimoto Y, et al. Ventricular fibrillation associated with complete right bundle branch block. Heart Rhythm. 2013;10:1028-35.

  33. 33.Knecht S, Sacher F, Wright M, Hocini M, Nogami A, Arentz T, et al. Long-term follow-up of idiopathic ventricular fibrillation ablation. A multicenter study. J Am Coll Cardiol. 2009;54:522-8.

  34. 34.Myerburg RJ, Marchlinski FE, Scheinman MM. Con-troversy on electrophysiology testing in patients with Brugada syndrome. Heart Rhythm. 2011;8: 1972-4.

  35. 35.Aizawa Y, Naitoh N, Washizuka T, Takahashi K, Uchiyama H, Shiba M, et al. Electrophysiological findings in idiopathic recurrent ventricular fibrilla-tion: special reference to mode of induction, drug testing, and long-term outcomes. Pacing Clin Elec-trophysiol. 1996;19:929-39.

  36. 36.Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. El Síndrome de Brugada: del laboratorio a la clínica. Barcelona: J&C Ediciones Médicas, S.L.; 2006.

  37. 37.Myerburg RJ. Scientific gaps in the prediction and prevention of sudden cardiac death. J Cardiovasc Electrophysiol. 2002;13:709-23.

  38. 38.Vouliotis AI, Gatzoulis KA, Dilaveris P, Stefanadis C. Multiple syncope mechanisms coexisting in a Bru-gada syndrome patient requiring a single therapeu-tic approach. Herz. 2013;38:309-12.

  39. 39.Antzelevitch C, Viskin S. Brugada syndrome: Cellular mechanisms and approaches to therapy. En: Gus-sak I, Antzelevitch C, eds. Electrical Diseases of the Heart. 2da. ed. London: Springer-Verlag; 2013. p. 497-536.

  40. 40.Antzelevitch C, Fish JM. Therapy for the Brugada syndrome. En: Kass RE, Clancy CE, eds. Basis and Treatment of Cardiac Arrhythmias (Handbook of Experimental Pharmacology. Vol 171). New York: Springer-Verlag; 2006. p. 305-30.

  41. 41.Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K. Brugada syndrome: 1992-2002. A historical perspective. J Am Coll Car-diol. 2003;41:1665-71.

  42. 42.Ikeda T. Brugada syndrome: current clinical aspects and risk stratification. Ann Noninvasive Electrocar-diol. 2002;7:251-62.

  43. 43.Kaufman ES, Rosenbaum DS. How to find the high-risk patient among individuals with a Brugada syn-drome-type electrocardiogram. J Cardiovasc Elec-trophysiol. 2005;16:52-3.

  44. 44.Monteforte N, Napolitano C, Priori SG. Genética y arritmias: aplicaciones diagnósticas y pronósticas. Rev Esp Cardiol. 2012;65:278-86.

  45. 45.Rollin A, Sacher F, Gourraud JB, Pasquié JL, Rackza F, Duparc A, et al. Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peri-pheral ECG leads in patients with Brugada syn-drome. Heart Rhythm. 2013;10:1012-8.

  46. 46.Sacher F, Arsac F, Wilton SB, Derval N, Denis A, de Guillebon M, et al. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm. 2012;9:1272-9.

  47. 47.Webster G, Berul CI. An update on channelopathies: from mechanisms to management. Circulation. 2013;127:126-40.

  48. 48.Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol. 2009;2:495-503.

  49. 49.Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome. Multicenter study in Japan. J Cardiovasc Electrophysiol 2007;18:1244-51.

  50. 50.Takagi M. Role of programmed electrical stimulation in Brugada syndrome. J Arrhythmia. 2013;29: 96-9.

  51. 51.Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247-346.

  52. 52.Gasparini M, Priori SG, Mantica M, Coltorti F, Napolitano C, Galimberti P, et al. Programmed electrical stimulation in Brugada syndrome: how reproducible are the results? J Cardiovasc Electrophysiol. 2002;13:880-7.

  53. 53.Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol. 2006;17:577-83.

  54. 54.Eckardt L, Probst V, Smits JP, Schulze-Bahr E, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257-63.

  55. 55.Chugh SS, Cingolani E. Identifying the high-risk Brugada syndrome patient: let us get personal. Heart Rhythm. 2012;9:917-8.

  56. 56.Ikeda T, Sakurada H, Sakabe K, Sakata T, Takami M, Tezuka N, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol. 2001;37:1628-34.

  57. 57.Mizusawa Y, Wilde AA. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5:606-16.

  58. 58.Sadanaga T. Electrocardiogram criteria of Brugada syndrome: much progress has been made, but still more investigation is needed. J Electrocardiol. 2012;45:443-4.

  59. 59.Wada T, Morita H. Clinical outcome and risk stratification in Brugada syndrome. J Arrhythmia. 2013; 29:100-9.

  60. 60.Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol. 2003;14:455-7.

  61. 61.Brugada J, Brugada R, Brugada P. Right bundlebranch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97:457-60.

  62. 62.Brugada J, Brugada R, Brugada P. Electrophysiologic testing predicts events in Brugada syndrome patients. Heart Rhythm 2011;8:1595-7.

  63. 63.Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002; 105:73-8.

  64. 64.Viskin S, Adler A, Rosso R. Brugada burden in Brugada syndrome: the way to go in risk stratification? Heart Rhythm. 2013;10:1019-20.

  65. 65.Benito B, Brugada J, Brugada R, Brugada P. Síndrome de Brugada. Rev Esp Cardiol. 2009;62:1297-315.

  66. 66.Antzelevitch C, Brugada P, Brugada J, Brugada R. Brugada syndrome: from cell to bedside. Curr Probl Cardiol. 2005;30:9-54.




2020     |     www.medigraphic.com